PAULA MCCARTER-CARLISLE: Open Payments
NPI 1942895958 · JASPER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,351 in 57 payments from 25 companies in 2025. Trend: 2023 $1,268 · 2024 $1,130 · 2025 $1,351
Food & beverage: $1,053Education: $298
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $199 |
| Novartis Pharmaceuticals Corporation | 6 | $145 |
| Janssen Biotech, Inc. | 2 | $115 |
| Merck Sharp & Dohme LLC | 6 | $114 |
| SEAGEN INC. | 1 | $100 |
| PFIZER INC. | 6 | $91 |
| Celgene Corporation | 4 | $87 |
| Daiichi Sankyo Inc. | 2 | $55 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| Syndax Pharmaceuticals, Inc. | 2 | $46 |
Products named: VENCLEXTA, KEYTRUDA, DARZALEX, REBLOZYL, KISQALI, XTANDI, REVUFORJ, clonoSEQ.
Industry payments across IN — which companies pay providers there.
